Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: MaxCyte Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aldeyra Therapeutics Inc. June 10, 202578.1%
-
Novavax Inc. June 13, 202459.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 20, 2026 | Novavax Inc. | Option exercise | +18,880 | — | — |
| Jun 17, 2026 | MaxCyte Inc. | Grant or award | +30,421 | — | — |
| Mar 19, 2026 | Aldeyra Therapeutics Inc. | Open-market purchase | +70,000 | $1.40 | $98,000 |
| Aug 13, 2025 | MaxCyte Inc. | Open-market purchase | +80,000 | $1.39 | $111,200 |
| Jun 18, 2025 | MaxCyte Inc. | Grant or award | +29,210 | — | — |
| Jun 12, 2025 | Novavax Inc. | Option exercise | +10,420 | — | — |
| Jun 12, 2024 | Novavax Inc. | Option exercise | +6,670 | — | — |
| Jun 11, 2024 | MaxCyte Inc. | Grant or award | +21,367 | — | — |
| Jun 10, 2023 | Novavax Inc. | Option exercise | +3,100 | — | — |
| Mar 29, 2023 | MaxCyte Inc. | Open-market purchase | +80,000 | $4.32 | $345,600 |
Questions about Richard Douglas
What boards is Richard Douglas on?
Richard Douglas sits on the boards of Aldeyra Therapeutics Inc., MaxCyte Inc. and Novavax Inc.
How long has Richard Douglas served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.